Amgen’s Good News Bad News for Regeneron?

By Ben Levisohn Lower cholesterol means a higher price for Amgen’s (AMGN) stock–but could be bad news for Regeneron Pharmaceuticals (REGN). Shares of Amgen have gained 2% to $ 122.95 today after the ...

France’s prime minister resigns

NEW YORK (MarketWatch) — French Prime Minister Jean-Marc Ayrault has resigned, according to several reports. The resignation came after Sunday’s election left French President Francois Ho...

Midday Movers: Amgen, Biogen, Priceline & More

Take a look at some of Monday’s midday movers: Amgen moved higher after a trial showed the pharmaceutical company’s new class of cholesterol drug was shown to lower bad cholesterol by as ...